NCT05534061View on ClinicalTrials.gov

Motivation, Syringe Exchange, and COVID-19

NACompletedINTERVENTIONAL
Enrollment

349

Participants

Timeline

Start Date

August 8, 2022

Primary Completion Date

June 30, 2023

Study Completion Date

June 30, 2023

Conditions
COVID-19 Pandemic
Interventions
BEHAVIORAL

Connect2Test

Brief motivational enhancement intervention to improve the likelihood of testing and vaccination among syringe exchange clients

Trial Locations (1)

97403

University of Oregon, Eugene

All Listed Sponsors
collaborator

National Institute on Drug Abuse (NIDA)

NIH

lead

University of Oregon

OTHER